Drug or medicament, unspecified. Drug or medicament, unspecified
Conditions
Interventions
The subjects in Creatine without training group will intake 300 mg/kg/day creatine monohydrate for 7 days.
Intervention 1: The subjects in Creatine plus training group will intake 300 mg/kg/day creatine monohydrate for 7 days. Intervention 2: The subjects in placebo group will intake 300 mg/kg/day maltodex
Treatment - Drugs
Placebo
The subjects in Creatine plus training group will intake 300 mg/kg/day creatine monohydrate for 7 days.
The subjects in placebo group will intake 300 mg/kg/day maltodexterine for 7 days.
Sponsors
University of Tabriz
Eligibility
Sex/Gender
Male
Age
18 Years to 26 Years
Inclusion criteria
Inclusion criteria: Inclusion:male; 18-26 years old; healthy; wrestling athletes;BMI<12; at least 3 years of professional wrestling experience; without any creatine consumption( during 3 months prior to the stud) Exclusion: Diseases; Injuries; Uncontrolled intake of creatine supplements during the period
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary formaldehyde. Timepoint: 24 hour before and after the Cr loading phase. Method of measurement: Gas chromatography–mass spectrometry (GC-MS).;Ceartine kinase (CK). Timepoint: 24 hour before and after supplementation protocol. Method of measurement: photometric methods with commercial kits (Bionik kit).;Lactate Dehydrogenase(LDH). Timepoint: 24 hour before and after supplementation protocol. Method of measurement: photometric methods with commercial kits (Bionik kit).;Alanine aminotransferase (ALT). Timepoint: 24 hour before and after supplementation protocol. Method of measurement: photometric methods with commercial kits (Bionik kit).;Aspartate aminotransferase (AST). Timepoint: 24 hour before and after supplementation protocol. Method of measurement: photometric methods with commercial kits (Bionik kit). | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood Pressure. Timepoint: 30 minutes before and after firs and last trainig session. Method of measurement: Aneroid blood pressure measurement. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Afshar Jafari
University of Tabriz
Outcome results
None listed